The cystic fibrosis drug Trikafta helps roughly 90 percent of people who have the deadly genetic disease. The drug enables patients to live a healthy life, start families, and think of a future.

The cystic fibrosis drug Trikafta helps roughly 90 percent of people who have the deadly genetic disease. The drug enables patients to live a healthy life, start families, and think of a future.

New limits on prescription drug prices could help millions afford life-saving drugs 03:42. For people with cystic fibrosis, like Sabrina Walker, Trikafta has been a life-changer.

TRIKAFTA ® was previously approved by Health Canada for use in people with CF aged 2 years and older with at least one F508del mutation and is now approved for 152 additional mutations.

Vertex Pharmaceuticals missed Wall Street estimates for quarterly results on Monday due to lower-than-expected sales of its cystic fibrosis (CF) drug Trikafta, sending shares down 2.5% after the bell.

Access to Trikafta is now at risk for several hundred people with cystic fibrosis, thanks to what some might consider to be good intentions. Skip to Main Content. FDA. research. weight loss.

From a young age, Emily Naismith watched her peers die from cystic fibrosis. The drug Trikafta gave her a future but she says forming a new identity has been complex.

Colorado’s new prescription drug review board decided that a medication costing more than $200,000 a year doesn’t qualify as “unaffordable,” based on the drug’s benefits to patients and ...

The approval was based on data from a 24-week open-label, two-part phase 3 study (ClinicalTrials.gov Identifier: NCT04537793) that evaluated the efficacy and safety of Trikafta in 75 children 2 to ...

Trio of scientists who developed the combination drug Trikafta are among the winners of five major awards in life sciences, physics and mathematics. The triple-drug combination Trikafta has given ...

Alyftek’s approval follows positive results from three Phase III clinical trials, including two 52-week studies – SKYLINE 102 and SKYLINE 103 – comparing its efficacy to Trikafta in patients ...

Even in countries where the drug is available, like the U.S., Trikafta’s cost before discounts is prohibitively expensive, clocking in at roughly $326,000 per patient per year, according to ...